https://www.worldpharmatoday.com/press-releases/anti-cancer-agent-vastin-obtained-approval-for-additional-indication-of-advanced-or-recurrent-cervical-cancer/ Magazine for the C-level Pharma Executives Mon, 23 May 2016 07:34:34 +0000 hourly 1 https://wordpress.org/?v=6.9.4